277 related articles for article (PubMed ID: 24185907)
1. Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer.
Jiang P; Zhang D
Int J Mol Sci; 2013 Oct; 14(11):21551-60. PubMed ID: 24185907
[TBL] [Abstract][Full Text] [Related]
2. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.
Perry NA; Fialkowski KP; Kaoud TS; Kaya AI; Chen AL; Taliaferro JM; Gurevich VV; Dalby KN; Iverson TM
Cell Signal; 2019 Nov; 63():109366. PubMed ID: 31352007
[TBL] [Abstract][Full Text] [Related]
3. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J
Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239
[TBL] [Abstract][Full Text] [Related]
4. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
[TBL] [Abstract][Full Text] [Related]
5. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity.
Tang BF; Yan RC; Wang SW; Zeng ZC; Du SS
Cancer Lett; 2023 Apr; 560():216126. PubMed ID: 36933780
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1.
Vulsteke V; Beullens M; Boudrez A; Keppens S; Van Eynde A; Rider MH; Stalmans W; Bollen M
J Biol Chem; 2004 Mar; 279(10):8642-7. PubMed ID: 14699119
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma.
Kiseljak-Vassiliades K; Zhang Y; Kar A; Razzaghi R; Xu M; Gowan K; Raeburn CD; Albuja-Cruz M; Jones KL; Somerset H; Fishbein L; Leong S; Wierman ME
Endocrinology; 2018 Jul; 159(7):2532-2544. PubMed ID: 29790920
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Overexpression of Wild Type and Kinase-Dead MELK in Fibroblasts and Keratinocytes, Potential Implications for Skin Wound Healing and Cancer.
Szymański Ł; Lieto K; Zdanowski R; Lewicki S; Tassan JP; Kubiak JZ
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175795
[TBL] [Abstract][Full Text] [Related]
9. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
Beke L; Kig C; Linders JT; Boens S; Boeckx A; van Heerde E; Parade M; De Bondt A; Van den Wyngaert I; Bashir T; Ogata S; Meerpoel L; Van Eynde A; Johnson CN; Beullens M; Brehmer D; Bollen M
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26431963
[TBL] [Abstract][Full Text] [Related]
10. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
[TBL] [Abstract][Full Text] [Related]
11. Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers.
Ganguly R; Hong CS; Smith LG; Kornblum HI; Nakano I
Mol Cancer Ther; 2014 Jun; 13(6):1393-8. PubMed ID: 24795222
[TBL] [Abstract][Full Text] [Related]
12. Enigmatic MELK: The controversy surrounding its complex role in cancer.
McDonald IM; Graves LM
J Biol Chem; 2020 Jun; 295(24):8195-8203. PubMed ID: 32350113
[TBL] [Abstract][Full Text] [Related]
13. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.
Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM
Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640
[TBL] [Abstract][Full Text] [Related]
14. MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies.
Thangaraj K; Ponnusamy L; Natarajan SR; Manoharan R
Drug Discov Today; 2020 Dec; 25(12):2161-2173. PubMed ID: 33010478
[TBL] [Abstract][Full Text] [Related]
15. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
[TBL] [Abstract][Full Text] [Related]
16. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.
Marie SK; Okamoto OK; Uno M; Hasegawa AP; Oba-Shinjo SM; Cohen T; Camargo AA; Kosoy A; Carlotti CG; Toledo S; Moreira-Filho CA; Zago MA; Simpson AJ; Caballero OL
Int J Cancer; 2008 Feb; 122(4):807-15. PubMed ID: 17960622
[TBL] [Abstract][Full Text] [Related]
17. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract][Full Text] [Related]
18. MELK-a conserved kinase: functions, signaling, cancer, and controversy.
Ganguly R; Mohyeldin A; Thiel J; Kornblum HI; Beullens M; Nakano I
Clin Transl Med; 2015; 4():11. PubMed ID: 25852826
[TBL] [Abstract][Full Text] [Related]
19. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
Chlenski A; Park C; Dobratic M; Salwen HR; Budke B; Park JH; Miller R; Applebaum MA; Wilkinson E; Nakamura Y; Connell PP; Cohn SL
Mol Cancer Ther; 2019 Mar; 18(3):507-516. PubMed ID: 30674566
[TBL] [Abstract][Full Text] [Related]
20. Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.
Kig C; Beullens M; Beke L; Van Eynde A; Linders JT; Brehmer D; Bollen M
J Biol Chem; 2013 Aug; 288(33):24200-12. PubMed ID: 23836907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]